Cell cryopreservation is the process of preserving cells or tissues by cooling them to very low sub-zero temperatures. It involves slowing life processes by lowering the temperature of the cell suspension. This allows viable long-term storage at cryogenic temperatures. The process is widely used in medical applications such as stem cell therapies, organ transplantations, and fertility preservation. Growing prevalence of chronic diseases and increasing number of transplant surgeries have boosted the demand for cryopreserved cells and tissues. Moreover, rising investments in stem cell research have driven the adoption of cell cryopreservation techniques for preserving cells and tissues.
The Global Cell Cryopreservation Market Size is estimated to be valued at US$ 228.8 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Increasing demand for preserving cells and tissues in stem cell research: Stem cell research involves harvesting and storing stem cells sourced from various tissues such as bone marrow, adipose tissue, and umbilical cord blood. Cell cryopreservation plays a vital role in stockpiling stem cells while avoiding changes during storage. For instance, cryopreservation helps in maintaining the viability and functionality of harvested stem cells for long term usage in transplantation and regenerative therapies.
Growing prevalence of chronic diseases and rise in organ transplantations: Rising burden of chronic diseases worldwide and increasing number of organ transplantations have augmented the demand for cryopreserved cells and tissues. Cell cryopreservation allows safe and viable storage of bio-specimen to be used in clinical applications for replacing damaged cells/tissues.
Segment Analysis
The cell cryopreservation market is dominated by the stem cell segment which holds around 45% share of the overall market. Stem cells find wide application in research, drug discovery and regenerative medicine. The growing stem cell therapy industry and increasing investments in R&D are driving demand for stem cell cryopreservation. Sperm cell preservation is another major segment owing to rising male infertility rates. Egg/oocyte cryopreservation segment is emerging on account of delaying childbearing age among women and rising success rates of IVF treatments.
PEST Analysis
Political: Regulations supporting stem cell research and funding for biotechnology have boosted the market. However, ethical concerns around embryonic stem cells in some countries act as a restraint.
Economic: Growing healthcare expenditure, increasing biotech industry investments in developed nations, and demand for cost-effective fertility preservation are fueling market revenues.
Social: Rise in fertility related issues, delayed pregnancies, growing acceptance of stem cell therapies are positively impacting the market.
Technological: Advancements in controlled rate freezing techniques, cryoprotectants and automated monitoring systems have improved cell survival rates post-thaw leading to market growth.
Key Takeaways
The global cell cryopreservation market is expected to witness high growth over the forecast period owing to factors such as rising infertility rates, increase in fertility preservation procedures and stem cell banking, growing acceptance of stem cell therapies, and advancements in cryopreservation technology. The global cell cryopreservation market is estimated to be valued at US$ 228.8 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030.
Regional analysis
North America dominates the global market due to developed healthcare infrastructure, favorable reimbursement policies, increasing stem cell research funding and rising fertility preservation rates in the region. Asia Pacific is expected witness fastest growth led by China and India on account of rising medical tourism, increase in healthcare expenditure and growth of the biotech industry.
Key players
Key players operating in the cell cryopreservation market are BASF, DSM, Kemin Industries, Naturex, Synthite Industries, Aarkay Food Products, Dohler, and Sensient Technologies. Vitablend is another leading player in the natural colors industry providing nature identical and natural colors and flavors.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
